Armata AP-SA02 shows promise for SAB in Phase IIa trial, underscoring growing potential of phage therapy: GlobalData Read more
CEPI, University of Oxford and Serum Institute to establish investigational Nipah virus vaccine reserve Read more
Merck & Co., Inc. and Eisai announce Phase 3 trial results for WELIREG plus LENVIMA in advanced renal cell carcinoma Read more
Akums Drugs & Pharmaceuticals begins construction of first overseas manufacturing facility in Zambia Read more